<br /> <b>Warning</b>: Undefined array key "mm" in <b>/www/wwwroot/www.ai-bt.com/si.php</b> on line <b>10</b><br /> <br /> <b>Deprecated</b>: trim(): Passing null to parameter #1 ($string) of type string is deprecated in <b>/www/wwwroot/www.ai-bt.com/si.php</b> on line <b>10</b><br /> Why interferon beta 1b was licensed is a mystery.

Literature DB >> 8704553

Why interferon beta 1b was licensed is a mystery.

Abstract

Year: 1996 PMID： 8704553 PMCID： PMC2351684 DOI： 10.1136/bmj.313.7052.297c

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

2 in total

1. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.

Authors:
Journal: Neurology Date: 1995-07 Impact factor: 9.910

2. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.

Authors:
Journal: Neurology Date: 1993-04 Impact factor: 9.910

2 in total

3 in total

1. Use of interferon beta 1b for multiple sclerosis. Patients will put up with side effects because of their desire to beat the disease.

Authors: M Chellingsworth
Journal: BMJ Date: 1996-11-16

2. Use of interferon beta 1b for multiple sclerosis. Importance of relapses must not be underestimated.

Authors: P Cardy
Journal: BMJ Date: 1996-11-16

3. Use of interferon beta 1b for multiple sclerosis. Manufacturer defends the drug.

Authors: P N Longthorne
Journal: BMJ Date: 1996-11-16

3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.